Johns Hopkins Medicine

mRNA vaccines can help the body fight cancer, a new study found, yet when we look at what has been called ‘vaccine hesitancy’ we see many people are suspicious of vaccines in general, let alone mRNA vaccines. Johns Hopkins mRNA … Why were so many people hesitant to take mRNA vaccines? Elizabeth Tracey reports Read More »

People with lung cancer and melanoma who were receiving immunotherapies and got a Covid vaccine saw dramatically improved survival compared with folks who did not get the vaccine, a recent study shows. mRNA expert Jeff Coller at Johns Hopkins muses … What is it about mRNA vaccines that helps us fight cancer? Elizabeth Tracey reports Read More »

People undergoing immunotherapy treatment for cancer and who got a Covid vaccine survived longer than those who did not get the vaccine, a new study finds. Jeff Coller, an mRNA expert at Johns Hopkins, examines why this hasn’t been seen … Why haven’t we seen cancer fighting effects with vaccines other than the Covid vaccines? Elizabeth Tracey reports Read More »

If you were being treated for lung cancer or melanoma with immunotherapy and you received a Covid vaccine, you got a surprising benefit: you were twice as likely to survive your cancer as those who did not get a vaccine, … mRNA could comprise a generic vaccine to be used for cancer, Elizabeth Tracey reports Read More »

People with lung cancer or melanoma who were receiving immunotherapy and got a Covid vaccine within 100 days of initiating treatment saw dramatically improved survival compared to those folks who did not receive a vaccine, a new study shows. mRNA … The benefit of mRNA vaccines in cancer treatment is ongoing, Elizabeth Tracey reports Read More »

Combating cancer may soon include immunization with an mRNA vaccine, as studies accumulate demonstrating their benefit in revving up the immune system against the disease. mRNA expert Jeff Coller at Johns Hopkins says this is one way to engage your … mRNA vaccines take advantage of the body’s own systems, Elizabeth Tracey reports Read More »

Receipt of an mRNA vaccine for Covid within 100 days of beginning immunotherapy for lung cancer or melanoma increased a person’s survival likelihood by a factor of two or greater, a new study shows. Johns Hopkins mRNA expert Jeff Coller … Might mRNA vaccines replace chemotherapy for cancer treatment? Elizabeth Tracey reports Read More »

mRNA vaccines saved millions of lives during the Covid-19 pandemic. Now a new study points to their effectiveness in helping people survive cancer. The study looked at people who received a Covid vaccine within 100 days of starting immunotherapy for … Can mRNA vaccines treat cancer? Elizabeth Tracey reports Read More »

This episode of Vital Conversations features Dr. Steve Kravet, president of Johns Hopkins Community Physicians (JHCP), who discusses the organization’s growth and innovative strategies to enhance clinician well-being and retention. Access the podcast here. Have an idea for a podcast? Email owb@jhmi.edu.

Testing a fluid known as cerebrospinal fluid, or CSF, found surrounding the brain and spinal cord, reveals a lot about brain tumors and the immune response to them. Johns Hopkins neurosurgery department director Chetan Bettegowda and test developer says this … Can a new test of cerebrospinal fluid be used for many diseases of the brain and spinal cord? Elizabeth Tracey reports Read More »

Tumor components and immune response indicators can be found in cerebrospinal fluid, or CSF, when someone has a brain tumor, in a new test developed by Chetan Bettagowda, director of neurosurgery at Johns Hopkins and one of the test’s developers.  … Cerebrospinal fluid may hold the keys to brain cancer identification and treatment, Elizabeth Tracey reports Read More »

Your immune system has everything to do with how your body responds to cancer, and brain tumors are no exception. A new test aims to assess that along with characterizing the tumor itself. Chetan Bettegowda, director of neurosurgery at Johns … What does your immune response have to do with brain tumors? Elizabeth Tracey reports Read More »

Your brain and spinal cord are floating in something called cerebrospinal fluid, or CSF, and when brain tumors develop they shed cells and cellular components into this fluid. A new test developed by director of neurosurgery Chetan Bettegowda at Johns … Cerebrospinal fluid can tell lots about brain tumors, Elizabeth Tracey reports Read More »

When someone is thought to have a brain tumor procedures to make the diagnosis may be risky or invasive, so a new test developed by Chetan Bettegowda, director of the department of neurosurgery at Johns Hopkins and colleagues is a … Can assessments of brain cancers be done with cerebrospinal fluid? Elizabeth Tracey reports Read More »

How does listening to patients transform cancer care? In part two of Medicine Made General’s conversation on cancer survivorship, Johns Hopkins researcher Claire Snyder, PhD, MHS, returns to explain how her work helps patients’ voices shape their care. She discusses … Ep 5 Part 2: The Power of the Patient Voice in Cancer Care | Medicine Made General Read More »

In this episode of Medicine Made General, Johns Hopkins cancer survivorship researcher Claire Snyder, PhD, MHS, joins hosts Dr. Bimal Ashar and Katie Caviness-Crolley to explore what survivorship really means—and why it begins at diagnosis, not after treatment ends. Dr. Snyder discusses how … Ep 5 Part 1: Caring for the Whole Person: Through Cancer & Beyond | Medicine Made General Read More »

AI assisted colonoscopy, where a computer helped interpret images seen during the procedure, resulted in endoscopists being less adept at recognizing precancerous lesions known as polyps, a recent study finds. Kimmel Cancer Center director William Nelson at Johns Hopkins comments. … When you have screening colonoscopy should you worry about the endoscopist’s skills? Elizabeth Tracey reports Read M...

If you’ve been treated for early breast cancer your overall risk for recurrence is small, a new large, long term study finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says these risks can be pinned to … Small risks of recurrent breast cancer may exist after treatment, Elizabeth Tracey reports Read More »

Women who’ve had early breast cancer and been treated can likely lay their worries about recurrence to rest, a new study concludes. Johns Hopkins Kimmel Cancer Center director William Nelson says that’s the conclusion of this very large, long term … Most women who’ve had early breast cancer are not at high risk for recurrence, Elizabeth Tracey reports Read More »

People who’ve had colorectal cancer and have a known mutation should likely take aspirin to help prevent disease recurrence, according to a new study. The benefit of aspirin in preventing cancers has been shown before in the skin cancer melanoma, … Aspirin may be of benefit in a number of cancers, Elizabeth Tracey reports Read More »

People who’ve had colorectal cancer and who have a mutation known as  PI3 kinase benefit from taking asprin to prevent recurrence, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the findings. Nelson:  There were … What is the benefit of asprin in reducing colorectal cancer recurrence? Elizabeth Tracey reports Read More »

Transcript Using CT scanning in children should be limited, a recent study concludes, finding that about one in ten cancers in kids were likely related to imaging studies using ionizing radiation. Kimmel Cancer Center director William Nelson at Johns Hopkins … Care should be taken when using CT in kids, Elizabeth Tracey reports Read More »

CT scans in children, especially those that image bones where bone marrow is found, increase the risk for certain cancers, a new study finds. And the more scans the kids have the greater the risk. William Nelson, director of the … What is the cancer risk posed by CT scans in kids? Elizabeth Tracey reports Read More »

RNA is easier to detect and points toward cancer activity better than DNA testing, a recent study concludes. Johns Hopkins Kimmel Cancer Center director William Nelson says there’s an even more accurate method on the horizon. Nelson: Will RNA sequencing … Will RNA based tests form the basis for cancer screening and monitoring? Elizabeth Tracey reports Read More »

Using blood tests to look for cancer and cancer recurrence has been an area of active research for some time now, with a new study pointing to RNA rather than DNA for detection. William Nelson, director of the Kimmel Cancer … Can RNA provide a way to look for cancer recurrence? Elizabeth Tracey reports Read More »